Tokyo Markets | Best Design Agency

Your Research Could Save Lives.
Why Does Your Website Need an MD to Understand?

Tokyo's Japanese corporate access funds transformative science—but only when they understand it. We translate breakthrough research into investable narratives.

Book a Discovery Call

ELI5 Without Dumbing Down

We don't just skin APIs. Selected work for our premium clients.

Gene Therapy

Science Simplified

Made CRISPR accessible to investor audiences.

$30M Series A Closed Medical Device

Regulatory-Ready

FDA-compliant marketing that actually converts.

200% Demo Request Increase Diagnostics

Patient-First Portal

Complex results made understandable.

95% Patient Comprehension Rate

We Are Your Scientific Simplification

Your science is groundbreaking. Peer-reviewed. Potentially world-changing. But your website reads like a journal abstract. Here's the problem: investors aren't all scientists. Patients aren't all doct...

Jargon Audit

We identify every term that loses a non-expert. Then we translate—without losing scientific precision.

Visual Mechanism

We create visualizations that explain your science. Mechanisms of action, pathways, and processes made intuitive.

Regulatory-Ready Design

We design around FDA, EMA, and other regulatory constraints. No claims you can't make, no promises you can't keep.

Common Questions

How do you handle regulatory constraints in marketing?

We work within FDA, EMA, and other regulatory frameworks. We know what claims you can make and design around those constraints—compliant but still compelling.

Can you work with our scientific team?

Yes. We translate between scientists and markets. Your team ensures accuracy; we ensure accessibility. The result: scientifically precise, commercially clear.

What about HIPAA compliance for patient-facing products?

We design with HIPAA requirements built in. Patient data visualization, portal access, and communication tools that meet compliance standards.

How do you make complex science visual?

We create custom visualizations—mechanisms of action, molecular processes, clinical pathways—that make abstract concepts tangible without oversimplifying.

Do you work with pre-clinical companies?

Yes. Early-stage biotech often needs the strongest messaging—you're asking investors to bet on science, not revenue. We make that science investable.

Global Innovation Hubs We Serve:

London New York San Francisco Dubai Singapore Berlin

Your Research Could Save Lives.Why Does Your Website Need an MD to Understand?